NATACYN
NATACYN (natamycin ophthalmic suspension) 5% Sterile
Approved
Approval ID
2818fcb8-5bac-41fb-864e-3b598308a428
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 9, 2023
Manufacturers
FDA
Eyevance Pharmaceuticals, LLC
DUNS: 080876046
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
natamycin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71776-005
Application NumberNDA050514
Product Classification
M
Marketing Category
C73594
G
Generic Name
natamycin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateOctober 9, 2023
FDA Product Classification
INGREDIENTS (5)
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
NATAMYCINActive
Quantity: 50 mg in 1 mL
Code: 8O0C852CPO
Classification: ACTIB